tiprankstipranks
Trending News
More News >
Takara Bio Inc. (JP:4974)
:4974
Japanese Market

Takara Bio Inc. (4974) Financial Statements

Compare
2 Followers

Takara Bio Inc. Financial Overview

Takara Bio Inc.'s market cap is currently ¥98.74B. The company's EPS TTM is ¥-44.85; its P/E ratio is -15.47; and it has a dividend yield of 2.18%. Takara Bio Inc. is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 45.04B¥ 43.51B¥ 78.14B¥ 67.70B¥ 46.09B
Gross Profit¥ 26.07B¥ 26.91B¥ 44.77B¥ 49.21B¥ 31.87B
Operating Income¥ 2.26B¥ 3.00B¥ 20.54B¥ 28.90B¥ 13.95B
EBITDA¥ 6.50B¥ 7.90B¥ 25.98B¥ 31.70B¥ 17.36B
Net Income¥ 1.04B¥ 1.48B¥ 16.01B¥ 19.85B¥ 9.55B
Balance Sheet
Cash & Short-Term Investments¥ 29.55B¥ 35.42B¥ 51.85B¥ 23.63B¥ 25.99B
Total Assets¥ 125.33B¥ 123.21B¥ 129.20B¥ 115.71B¥ 90.98B
Total Debt¥ 1.10B¥ 968.00M¥ 972.00M¥ 1.05B¥ 1.14B
Net Debt¥ -28.45B¥ -32.20B¥ -48.09B¥ -21.11B¥ -22.17B
Total Liabilities¥ 9.48B¥ 11.42B¥ 16.75B¥ 19.65B¥ 16.68B
Stockholders' Equity¥ 115.50B¥ 111.50B¥ 112.22B¥ 95.87B¥ 74.18B
Cash Flow
Free Cash Flow¥ -4.03B¥ -11.07B¥ 31.02B¥ -5.55B¥ 5.10B
Operating Cash Flow¥ 5.84B¥ 1.71B¥ 36.90B¥ 6.99B¥ 13.94B
Investing Cash Flow¥ -10.91B¥ -13.04B¥ -6.69B¥ -7.07B¥ -3.78B
Financing Cash Flow¥ -2.26B¥ -5.23B¥ -4.12B¥ -2.07B¥ -1.10B
Currency in JPY

Takara Bio Inc. Earnings and Revenue History

Takara Bio Inc. Debt to Assets

Takara Bio Inc. Cash Flow

Takara Bio Inc. Forecast EPS vs Actual EPS